報價延遲最少15分鐘:2025/02/01 11:55 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.29 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-19.96/--
|
|
企業價值
10.06M
|
| 資產負債 |
|
每股賬面淨值
-13.34
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
1.26M
|
|
每股收益
1.11
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/01 11:55 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders. |